INM icon

InMed Pharmaceuticals

15 hedge funds and large institutions have $266K invested in InMed Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
3
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AI
1
AdvisorShares Investments
Maryland
$172K 733,296 +733,296 New
UBS Group
2
UBS Group
Switzerland
$50.3K 212,039 +212,039 New
Citadel Advisors
3
Citadel Advisors
Florida
$13.3K 56,666 +44,569 +368%
Renaissance Technologies
4
Renaissance Technologies
New York
$11.9K 50,296 +50,296 New
HF
5
HRT Financial
New York
$8K 38,369 +22,373 +140%
VF
6
Virtu Financial
New York
$7K 28,415 -58,269 -67%
BBA
7
Baader Bank Aktiengesellschaft
Germany
$3.84K 22,611 +22,611 New
Bank of America
8
Bank of America
North Carolina
$24 100
Osaic Holdings
9
Osaic Holdings
Arizona
$5 27 -5 -16%
AWM
10
AllSquare Wealth Management
New York
$5 21
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$5 19 +19 New
GRP
12
Global Retirement Partners
California
$1 6
SM
13
Sabby Management
Florida
-307,236 Closed
XT
14
XTX Topco
Cayman Islands
-17,819 Closed
Qube Research & Technologies (QRT)
15
Qube Research & Technologies (QRT)
United Kingdom
-200 Closed
TWC
16
TD Waterhouse Canada
Ontario, Canada
-85 Closed
Toronto Dominion Bank
17
Toronto Dominion Bank
Ontario, Canada
-2 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$0 24 -1 -4%
CFGS
19
Concourse Financial Group Securities
Alabama
GCM
20
Gables Capital Management
Florida
$0 1
BCV
21
Banque Cantonale Vaudoise
Switzerland
$0 125 +125 New